REFERENCES
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. In J Cancer 2010;127:2893–2917.
- Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10–30.
- Turner N, Moretti E, Siclari O, Migliaccio I, Santarpia L, DΓÇÖIncalci M, Piccolo S, Veronesi A, Zambelli A, Del Sal G, Di Leo A. Targeting triple negative breast cancer: is p53 the answer? Cancer Treat Rev 2013;39:541–550.
- Shibatohge M, Kariya Ki, Liao Y, Hu CD, Watari Y, Goshima M, Shima F, Kataoka T. Identification of PLC210, a Caenorhabditis elegans phospholipase C, as a putative effector of ras. J Biol Chem 1998;273:6218–6222.
- Harden TK, Sondek J. Regulation of phospholipase C isozymes by ras superfamily GTPases. Annu Rev Pharmacol Toxicol 2006;46:355–379.
- Bye H, Prescott NJ, Lewis CM, Matejcic M, Moodley L, Robertson B, Rensburg Cv, Parker MI, Mathew CG. Distinct genetic association at the PLCE1 locus with oesophageal squamous cell carcinoma in the South African population. Carcinogenesis 2012;33:2155–2161.
- Chen YZ, Cui XB, Hu JM, Zhang WJ, Li SG, Yang L, Shen XH, Liu CX, Pan QF, Yu SY, Yuan XL, Yang L, Gu WY, Chen JZ, Wang LD, Li F. Overexpression of PLCE1 in Kazakh esophageal squamous cell carcinoma: implications in cancer metastasis and aggressiveness. APMIS 2013;121(10):908–918.
- Gu H, Ding G, Zhang W, Liu C, Chen Y, Chen S, Jiang P. Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population. Mol Biol Rep 2012;39:9105–9111.
- Hu H, Yang J, Sun Y, Yang Y, Qian J, Jin L, Wang M, Bi R, Zhang R, Zhu M, Sun M, Ma H, Wei Q, Jiang G, Zhou X, Chen H. Putatively functional PLCE1 variants and susceptibility to esophageal squamous cell carcinoma (ESCC): a case-control study in Eastern Chinese populations. Ann Surg Oncol 2012;19:2403–2410.
- Yuan LJ, Jin TB, Yin JK, Du XL, Wang Q, Dong R, Wang SZ, Cui Y, Chen C, Lu JG. Polymorphisms of tumor-related genes IL-10, PSCA, MTRR and NOC3L are associated with the risk of gastric cancer in the Chinese Han population. Cancer Epidemiol 2012;36:e366–e372.
- Wang X, Zhou C, Qiu G, Yang Y, Yan D, Xing T, Fan J, Tang H, Peng Z. Phospholipase C epsilon plays a suppressive role in incidence of colorectal cancer. Med Oncol 2012;29:1051–1058.
- Bieging KT, Attardi LD. Deconstructing p53 transcriptional networks in tumor suppression. Trends Cell Biol 2012;22:97–106.
- Liu YY. Resuscitating wild-type p53 expression by disrupting ceramide glycosylation: a novel approach to target mutant p53 tumors. Cancer Res 2011;71:6295–6299.
- Baldwin AS. Regulation of cell death and autophagy by IKK and NF-kappa B: critical mechanisms in immune function and cancer. Immunol Rev 2012;246:327–345.
- Chen Fh, Lu N, Zhang Hw, Zhao L, He Lc, Sun Hp, You Qd, Li Zy, Guo Ql. LYG-202 augments tumor necrosis factor-alpha induced apoptosis via attenuating casein kinase 2-dependent nuclear factor-kappa B pathway in HepG2 cells. Mol Pharmacol 2012;82:958–971.
- Toldo S, Breckenridge DG, Mezzaroma E, Van Tassell BW, Shryock J, Kannan H, Phan D, Budas G, Farkas D, Lesnefsky E, Voelkel N, Abbate A. Inhibition of apoptosis signal-regulating kinase 1 reduces myocardial ischemia-reperfusion injury in the mouse. J Am Heart Assoc 2012;1: e002360.
- Stiburek L, Vesela K, Hansikova H, Hulkova H, Zeman J. Loss of function of Sco1 and its interaction with cytochrome c oxidase. Am J Physiol Cell Physiol 2009;296:C1218–C1226.